RBC Capital Increases Gilead Sciences Price Target to GBX 80 (IBT)
Equities research analysts at RBC Capital increased their target price on shares of Gilead Sciences (LON:IBT) from GBX 72 ($1.16) to GBX 80 ($1.29) in a research note issued to investors on Wednesday, AnalystRatingsNetwork.com reports. The firm currently has an “outperform” rating on the stock. RBC Capital’s price objective would suggest a potential downside of 73.52% from the company’s current price.
A number of other firms have also recently commented on IBT. Analysts at Needham & Company raised their price target on shares of Gilead Sciences from GBX 70 ($1.13) to GBX 85 ($1.38) in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Gilead Sciences from GBX 67 ($1.08) to GBX 80 ($1.29) in a research note to investors on Wednesday. They now have an “outperform” rating on the stock. Finally, analysts at Citigroup Inc. raised their price target on shares of Gilead Sciences from GBX 75 ($1.21) to GBX 85 ($1.38) in a research note to investors on Wednesday. Fourteen analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of GBX 76.59 ($1.24).
Gilead Sciences (LON:IBT) traded up 0.70% on Wednesday, hitting GBX 302.103. 60,705 shares of the company’s stock traded hands. Gilead Sciences has a 1-year low of GBX 1.94 and a 1-year high of GBX 3.2855. The stock has a 50-day moving average of GBX 2.89 and a 200-day moving average of GBX 2.67.
International Biotechnology Trust plc is an investment company. The investment objective of the Company is to achieve long-term capital growth by investing primarily in biotechnology and other life sciences companies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.